IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)

Clinical trial NCT00351949 · COMPLETED

Trial details

NCT number: NCT00351949
Sponsor: Immutep S.A.S.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Stage IV Renal Cell Carcinoma

Start date: 2005-09-01
Primary completion: 2008-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.